The FDA has approved #Hovilpri (#pritelivir) for adults with weakened immune systems who have mucocutaneous lesions caused by HSV infection that have not responded to other treatments.
🧪Pritelivir for research use from MedChemExpress: https://www.medchemexpress.com/BAY-57-1293.html

The US FDA has approved #pritelivir, an oral #HSV therapy for immunocompromised adults whose lesions persist despite standard antivirals. Complete healing by day 28: 63% vs 34% with comparator treatments. A new mechanism and a meaningful advance but not a herpes cure. lnkd.in/p/e5ATUMYp